|
ORMP Oramed Pharmaceuticals, Inc. 1176309 |
| Balance Sheet |
|
Current Assets
|
$53,407,000.00 |
|
Assets
|
$369,643,000.00 |
|
Current Liabilities
|
$10,731,000.00 |
|
Equity
|
$199,744,000.00 |
|
Shares Out
|
41314211.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,115,000.00 |
|
Investing Cash Flow
|
$-15,178,000.00 |
| Market Analysis |
Market Cap
|
$197,895,070.69 |
|
Price
|
$4.79 |
|
BVPS
|
4.83 |
|
PB
|
0.99 |
|
EPS
|
1.90 |
|
PE
|
1.80 |
|
PS
|
98.95 |
|
FCF
|
$-3,122,000.00 |
|
| Dividends |
|
Dividend Increment
|
Annual |
|
Dividend Amount
|
0.25 |
|
Dividend Yield |
4.91% |
|
Dividend Data Last Updated
|
2026-09-01 09:32:48 |
|
| Jan |
Feb |
Mar |
| Ex: 2026-01-16 |
Pay: 2026-01-26 |
|
|
|
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
1.50 |
|
|
2026-05-19 |
0.91 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
0.31 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
1.26 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ORMP documents filed with the SEC.
ORMP Filings
Clear
